N. Sacktor

N. Freimer, P. Thompson, J. Becker, 2012, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

Neuropsychological phenotypes among men with and without HIV disease in the multicenter AIDS cohort study

J. Becker, L. Kingsley, E. Miller, 2018, AIDS.

Transcriptome analyses identify key cellular factors associated with HIV-1-associated neuropathogenesis in infected men

Narasimhan J. Venkatachari, Z. Bar-Joseph, J. Becker, 2017, AIDS.

Diabetes, Insulin Resistance, and Dementia Among HIV-1-Infected Patients

O. Selnes, V. Valcour, N. Sacktor, 2005, Journal of acquired immune deficiency syndromes.

Evaluation of a screening tool for the identification of neurological disorders in rural Uganda

N. Nakasujja, R. Gray, N. Sacktor, 2020, Journal of the Neurological Sciences.

Identification of putative biomarkers for HIV-associated neurocognitive impairment in the CSF of HIV-infected patients under cART therapy determined by mass spectrometry

Linda Chang, R. Chaerkady, R. Moxley, 2014, Journal of NeuroVirology.

Validation of a Novel Computerized Performance-Based Functional Assessment for HIV Associated Neurocognitive Disorders

O. Selnes, R. Moxley, J. McArthur, 2010 .

Effects of subperineurial injections of very-long-chain and medium-chain fatty acids into rat sciatic nerve.

H. Moser, A. Moser, N. Sacktor, 1986, Neurochemical pathology.

Aging exacerbates extrapyramidal motor signs in the era of highly active antiretroviral therapy

V. Valcour, N. Sacktor, M. Watters, 2011, Journal of NeuroVirology.

Midlife adiposity predicts cognitive decline in the prospective Multicenter AIDS Cohort Study

J. Becker, E. Martin, N. Sacktor, 2019, Neurology.

Original Contribution Inflammation andRisk of Depression in HIV: Prospective Findings From the Multicenter AIDS Cohort Study

M. Irwin, Steven Wolinsky, N. Sacktor, 2019 .

The epidemiology of human immunodeficiency virus-associated neurological disease in the era of highly active antiretroviral therapy.

N. Sacktor, 2002, Journal of neurovirology.

Protein-Free Efavirenz Concentrations in Cerebrospinal Fluid and Blood Plasma Are Equivalent: Applying the Law of Mass Action To Predict Protein-Free Drug Concentration

J. McArthur, N. Sacktor, C. Hendrix, 2013, Antimicrobial Agents and Chemotherapy.

Increased vulnerability of ApoE4 neurons to HIV proteins and opiates: Protection by diosgenin and l-deprenyl

M. Mattson, K. Chen, J. McArthur, 2006, Neurobiology of Disease.

Identification of Youthful Neurocognitive Trajectories in Adults Aging with HIV: A Latent Growth Mixture Model

Michael J. Taylor, F. Vaida, C. Fennema-Notestine, 2021, AIDS and Behavior.

Impairments of Motor Function While Multitasking in HIV

Sharif I. Kronemer, C. Marvel, N. Sacktor, 2017, Front. Hum. Neurosci..

Imaging glial cell activation with [11C]-R-PK11195 in patients with AIDS

T. Guilarte, M. Pomper, D. Wong, 2005, Journal of NeuroVirology.

A case-control study of HIV-1–related dementia and co-infection with HHV-8

E. Miller, B. Cohen, N. Sacktor, 2002, Neurology.

Modifications in acute phase and complement systems predict shifts in cognitive status of HIV-infected patients

I. Grant, T. Marcotte, J. McArthur, 2017, AIDS.

Informatic interrogation of CSF proteomic profiles from HIV-infected subjects implicates acute phase and complement systems in shifting cognitive status.

I. Grant, T. Marcotte, J. McArthur, 2017, AIDS.

Lower CSF Aβ is Associated with HAND in HIV-Infected Adults with a Family History of Dementia.

I. Grant, R. Heaton, D. Clifford, 2016, Current HIV research.

Overlapping features of polymyositis and inclusion body myositis in HIV-infected patients

A. Mammen, N. Sacktor, T. Lloyd, 2017, Neurology.

Impact of minocycline on cerebrospinal fluid markers of oxidative stress, neuronal injury, and inflammation in HIV-seropositive individuals with cognitive impairment

Julia L. Drewes, D. Clifford, M. Zink, 2014, Journal of NeuroVirology.

Baseline Neurocognitive Impairment (NCI) Is Associated With Incident Frailty but Baseline Frailty Does Not Predict Incident NCI in Older Persons With Human Immunodeficiency Virus (HIV).

R. Ellis, F. Palella, N. Sacktor, 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Randomized trial of minocycline in the treatment of HIV-associated cognitive impairment

D. Clifford, N. Nakasujja, N. Sacktor, 2013, Neurology.

Neurological Function and HIV Risk Behaviors of Female Prison Inmates

J. Shults, D. Kolson, W. V. van Gorp, 2007, The Journal of neuroscience nursing : journal of the American Association of Neuroscience Nurses.

Screening for HIV-associated neurocognitive disorders in perinatally infected adolescents: youth-International HIV Dementia Scale validation

Dan J Stein, H. Zar, L. Myer, 2019, AIDS.

Immunometabolic Reprogramming in Response to HIV Infection Is Not Fully Normalized by Suppressive Antiretroviral Therapy

T. Quinn, N. Nakasujja, Yanxun Xu, 2022, Viruses.

Beta-amyloid (Aβ) uptake by PET imaging in older HIV+ and HIV- individuals

James Robert Brašić, Amanda M. Brown, P. Barker, 2020, Journal of NeuroVirology.

Association of Marijuana Use with Changes in Cognitive Processing Speed and Flexibility for 17 Years in HIV-Seropositive and HIV-Seronegative Men

S. Shoptaw, E. Martin, R. Cook, 2019, Substance use & misuse.

Intraindividual variability in neurocognitive performance: No influence due to HIV status or self-reported effort

S. Horvath, J. Becker, E. Martin, 2018, Journal of clinical and experimental neuropsychology.

The association between physical activity and cognition in men with and without HIV infection

J. Becker, E. Miller, A. Ragin, 2017, HIV medicine.

The longitudinal and interactive effects of HIV status, stimulant use, and host genotype upon neurocognitive functioning

J. Sinsheimer, J. Becker, E. Miller, 2014, Journal of NeuroVirology.

HIV disease and diabetes interact to affect brain white matter hyperintensities and cognition

Jeffery R. Alger, T. Parrish, J. Becker, 2018, AIDS.

Cognitive trajectory phenotypes in human immunodeficiency virus infected patients

I. Grant, R. Heaton, T. Marcotte, 2019, Journal of acquired immune deficiency syndromes.

HIV-associated neurocognitive disorder — pathogenesis and prospects for treatment

David J. Volsky, Joseph L. Mankowski, Justin C. McArthur, 2016, Nature Reviews Neurology.

Prevalence of HIV-associated neurocognitive disorders in the Multicenter AIDS Cohort Study

Andrew Levine, James T Becker, Richard L Skolasky, 2016, Neurology.

HIV-associated neurocognitive disorder — pathogenesis and prospects for treatment

David J. Volsky, Joseph L. Mankowski, Justin C. McArthur, 2016, Nature Reviews Neurology.

Beta-amyloid (Aβ) uptake by PET imaging in older HIV+ and HIV- individuals

James Robert Brašić, Amanda M. Brown, P. Barker, 2020, Journal of NeuroVirology.

Cognitive Impairment Among Older Individuals with HIV Infection

N. Sacktor, D. Saylor, 2016, Current Geriatrics Reports.

Evolving clinical phenotypes in HIV-associated neurocognitive disorders

N. Sacktor, K. Robertson, 2014, Current opinion in HIV and AIDS.

Vascular risk factors, HIV serostatus, and cognitive dysfunction in gay and bisexual men

J. Becker, L. Kingsley, O. Selnes, 2009, Neurology.

Incidence of and risk factors for HIV-associated distal sensory polyneuropathy

K. Marder, M. Mcdermott, K. Kieburtz, 2002, Neurology.

The International HIV Dementia Scale: a new rapid screening test for HIV dementia

O. Selnes, N. Nakasujja, J. McArthur, 2005, AIDS.

Cerebrospinal fluid viral escape in aviremic HIV-infected patients receiving antiretroviral therapy: prevalence, risk factors and neurocognitive effects

I. Grant, R. Heaton, D. Clifford, 2019, AIDS.

Acylated proteins in Acholeplasma laidlawii

N. Sacktor, C. Dahl, J. Dahl, 1985, Journal of bacteriology.

Cognitive impairment in older HIV-1-seropositive individuals: prevalence and potential mechanisms.

V. Valcour, N. Sacktor, M. Watters, 2004, AIDS.

Human immunodeficiency virus‐associated neurocognitive disorders: Mind the gap

J. McArthur, N. Sacktor, A. Nath, 2010, Annals of neurology.

A multicenter trial of selegiline transdermal system for HIV-associated cognitive impairment

D. Katzenstein, K. Marder, K. Tashima, 2007, Neurology.

Benefits and risks of stavudine therapy for HIV-associated neurologic complications in Uganda

D. Clifford, N. Nakasujja, N. Sacktor, 2009, Neurology.

Second assessment of NeuroAIDS in Africa

J. Clements, D. Clifford, N. Nakasujja, 2008, Journal of NeuroVirology.

Depression symptoms and cognitive function among individuals with advanced HIV infection initiating HAART in Uganda

P. Allebeck, D. Clifford, N. Nakasujja, 2010, BMC psychiatry.

Novel markers of oxidative stress in actively progressive HIV dementia

R. Cutler, N. Sacktor, A. Nath, 2004, Journal of Neuroimmunology.

Dendritic Spine Injury Induced by the 8-Hydroxy Metabolite of Efavirenz

J. McArthur, N. Sacktor, Namandjé N. Bumpus, 2012, Journal of Pharmacology and Experimental Therapeutics.

Evolution of HIV dementia with HIV infection

A. Venkatesan, J. McArthur, N. Sacktor, 2008, International review of psychiatry.

Presence of Tat and transactivation response element in spinal fluid despite antiretroviral therapy.

Bryan R. Smith, F. Kashanchi, J. McArthur, 2019, AIDS.

HIV-associated neurologic disease incidence changes: Multicenter AIDS Cohort Study, 1990–1998

J. Becker, O. Selnes, C. Kleeberger, 2001, Neurology.

Nitrosative stress with HIV dementia causes decreased L-prostaglandin D synthase activity

J. McArthur, N. Sacktor, A. Nath, 2008, Neurology.

Serum neopterin level predicts HIV-related mortality but not progression to AIDS or development of neurological disease in gay men and parenteral drug users.

K. Marder, R. Mayeux, Y. Stern, 1995, Archives of neurology.

White matter damage, neuroinflammation, and neuronal integrity in HAND

C. Fennema-Notestine, I. Grant, R. Heaton, 2018, Journal of NeuroVirology.

Neurocognitive change in the era of HIV combination antiretroviral therapy: the longitudinal CHARTER study.

Michael J. Taylor, F. Vaida, C. Fennema-Notestine, 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Human immunodeficiency virus-associated dementia: An evolving disease

N. Sacktor, K. Conant, A. Nath, 2003, Journal of NeuroVirology.

Attenuated central nervous system infection in advanced HIV/AIDS with combination antiretroviral therapy.

K. Marder, Y. Stern, O. Selnes, 2004, Archives of neurology.

A comparison of performance-based measures of function in HIV-associated neurocognitive disorders

O. Selnes, J. McArthur, N. Sacktor, 2011, Journal of NeuroVirology.

A Comparison of Five Brief Screening Tools for HIV-Associated Neurocognitive Disorders in the USA and South Africa

N. Sacktor, J. McArthur, K. Thomas, 2016, AIDS and Behavior.

HIV immune complexes prevent excitotoxicity by interaction with NMDA receptors

N. Sacktor, A. Nath, M. Bianchet, 2013, Neurobiology of Disease.

Influence of highly active antiretroviral therapy on persistence of HIV in the central nervous system

N. Sacktor, A. Nath, 2006, Current opinion in neurology.

Combination antiretroviral therapy improves psychomotor speed performance in HIV-seropositive homosexual men

O. Selnes, B. Cohen, N. Sacktor, 1999, Neurology.

Osteopontin enhances HIV replication and is increased in the brain and cerebrospinal fluid of HIV-infected individuals

Amanda M. Brown, K. Marder, G. Schifitto, 2011, Journal of NeuroVirology.

Randomized trial of the platelet-activating factor antagonist lexipafant in HIV–associated cognitive impairment

S. Small, K. Marder, M. Mcdermott, 1999, Neurology.

The neurologic phenotype of South African patients with HIV-associated neurocognitive impairment.

S. Khoo, M. McCaul, N. Sacktor, 2020, Neurology. Clinical practice.

Heterogeneity in neurocognitive change trajectories among people with HIV starting antiretroviral therapy in Rakai, Uganda

T. Quinn, S. Lofgren, N. Nakasujja, 2019, Journal of NeuroVirology.

Pattern of neuropsychological performance among HIV positive patients in Uganda

T. Parsons, N. Nakasujja, N. Sacktor, 2007, BMC neurology.

Improvement in depressive symptoms after antiretroviral therapy initiation in people with HIV in Rakai, Uganda

T. Quinn, S. Lofgren, N. Nakasujja, 2021, Journal of NeuroVirology.

Lowest ever CD4 lymphocyte count (CD4 nadir) as a predictor of current cognitive and neurological status in human immunodeficiency virus type 1 infection—The Hawaii Aging with HIV Cohort

Michael Watters, O. Selnes, R. Paul, 2006, Journal of NeuroVirology.

Longitudinal psychomotor speed performance in human immunodeficiency virus-seropositive individuals: impact of age and serostatus

J. Becker, O. Selnes, E. Miller, 2010, Journal of NeuroVirology.

Sex-specific associations between cerebrospinal fluid inflammatory marker levels and cognitive function in antiretroviral treated people living with HIV in rural Uganda

T. Quinn, S. Lofgren, N. Nakasujja, 2020, Brain, Behavior, and Immunity.

Differences in Cognitive Function Between Women and Men With HIV

J. Becker, M. Young, E. Miller, 2018, Journal of acquired immune deficiency syndromes.

Differences in Neurocognitive Impairment Among HIV-Infected Latinos in the United States

I. Grant, R. Heaton, D. Clifford, 2017, Journal of the International Neuropsychological Society.

Neurocognitive Effects of Antiretroviral Initiation Among People Living With HIV in Rural Uganda.

T. Quinn, N. Nakasujja, R. Gray, 2020, Journal of acquired immune deficiency syndromes.

Peripheral inflammation and depressed mood independently predict neurocognitive worsening over 12 years

R. Heaton, D. Clifford, R. Ellis, 2022, Brain, behavior, & immunity - health.

Elevated Depressive Symptoms Are a Stronger Predictor of Executive Dysfunction in HIV-Infected Women Than in Men.

J. Becker, M. Young, V. Valcour, 2019, Journal of acquired immune deficiency syndromes.

Genome‐wide association study of HIV‐associated neurocognitive disorder (HAND): A CHARTER group study

Zhongming Zhao, N. Schork, P. Jia, 2017, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

Proceedings from the NIMH symposium on “NeuroAIDS in Africa: neurological and neuropsychiatric complications of HIV”

R. Paul, N. Nakasujja, N. Sacktor, 2016, Journal of NeuroVirology.

Prevalence and Correlates of Persistent HIV-1 RNA in Cerebrospinal Fluid During Antiretroviral Therapy

F. Vaida, C. Fennema-Notestine, R. Heaton, 2017, The Journal of infectious diseases.

Developing neuroprotective strategies for treatment of HIV-associated neurocognitive dysfunction.

N. Sacktor, A. Nath, J. Steiner, 2008, Future HIV therapy.

HIV neurocognitive disorders.

S. Lipton, I. Grant, H. Gendelman, 2005 .

Screening for human immunodeficiency virus (HIV) dementia in an HIV clade C-infected population in India

R. Bollinger, R. Paranjape, J. McArthur, 2006, Journal of NeuroVirology.

International neurocognitive normative study: neurocognitive comparison data in diverse resource-limited settings: AIDS Clinical Trials Group A5271

C. Marra, N. Sacktor, K. Robertson, 2016, Journal of NeuroVirology.

HIV subtype D is associated with dementia, compared with subtype A, in immunosuppressed individuals at risk of cognitive impairment in Kampala, Uganda.

O. Laeyendecker, D. Clifford, T. Quinn, 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Subcortical brain atrophy persists even in HAART-regulated HIV disease

Paul M. Thompson, Owen T. Carmichael, James T. Becker, 2011, Brain Imaging and Behavior.

A randomized, double-blind, placebo-controlled trial of deprenyl and thioctic acid in human immunodeficiency virus-associated cognitive impairment

N. Sacktor, 1998, Neurology.

Impact of glycemic status on longitudinal cognitive performance in men with and without HIV infection

J. Becker, F. Palella, E. Martin, 2018, AIDS.

Studying the neuropsychological sequelae of SARS-CoV-2: lessons learned from 35 years of neuroHIV research

J. Becker, N. Sacktor, A. Levine, 2020, Journal of NeuroVirology.

Predictors and Impact of Self-Reported Suboptimal Effort on Estimates of Prevalence of HIV-Associated Neurocognitive Disorders

J. Becker, E. Martin, N. Sacktor, 2017, Journal of acquired immune deficiency syndromes.

Cortical brain atrophy and intra-individual variability in neuropsychological test performance in HIV disease

Jeffery R. Alger, J. Becker, O. Selnes, 2016, Brain Imaging and Behavior.

Higher levels of plasma inflammation biomarkers are associated with depressed mood and quality of life in aging, virally suppressed men, but not women, with HIV

R. Heaton, D. Clifford, R. Ellis, 2020, Brain, behavior, & immunity - health.

Paresthesia Predicts Increased Risk of Distal Neuropathic Pain in Older People with HIV-Associated Sensory Polyneuropathy.

A. Simmons, F. Vaida, I. Grant, 2021, Pain medicine.

CCL3L1 gene copy number in individuals with and without HIV-associated neurocognitive disorder.

Amanda M. Brown, K. Marder, G. Schifitto, 2012, Current biomarker findings.

Vitamin D is not associated with HIV-associated neurocognitive disorder in Rakai, Uganda

N. Nakasujja, N. Sacktor, K. Robertson, 2019, Journal of NeuroVirology.

Vitamin D is not associated with HIV-associated neurocognitive disorder in Rakai, Uganda

N. Nakasujja, R. Gray, N. Sacktor, 2019, Journal of NeuroVirology.

Impact of Clade Diversity on Neuropsychological Outcomes

R. Paul, B. Brew, V. Valcour, 2009 .

Age, apolipoprotein E4, and the risk of HIV dementia: the Hawaii Aging with HIV Cohort

Y. Liu, O. Selnes, V. Valcour, 2004, Journal of Neuroimmunology.

Systolic Blood Pressure within an Intermediate Range May Reduce Memory Loss in an Elderly Hypertensive Cohort

J. Fleg, C. Kawas, N. Sacktor, 1999, Journal of geriatric psychiatry and neurology.

Correlates of HIV RNA concentrations in cerebrospinal fluid during antiretroviral therapy: a longitudinal cohort study.

F. Vaida, I. Grant, D. Clifford, 2019, The lancet. HIV.

Adiponectin and Interleukin-6, but not Adipose Tissue, are Associated with Worse Neurocognitive Function in HIV-Infected Men

J. Becker, W. Post, E. Miller, 2015, Antiviral therapy.

Cohort Profile: Recruitment cohorts in the neuropsychological substudy of the Multicenter AIDS Cohort Study.

J. Becker, L. Kingsley, O. Selnes, 2015, International journal of epidemiology.

The design of a diet restricted in saturated very long-chain fatty acids: therapeutic application in adrenoleukodystrophy.

H. Moser, N. Sacktor, F. R. Brown, 1984, The American journal of clinical nutrition.

Associative and predictive biomarkers of dementia in HIV-1–infected patients

M. Mattson, J. McArthur, R. Cutler, 2007, Neurology.

Reward, attention, and HIV-related risk in HIV+ individuals

Sharif I. Kronemer, C. Marvel, N. Sacktor, 2016, Neurobiology of Disease.

A novel computerized functional assessment for human immunodeficiency virus-associated neurocognitive disorder

O. Selnes, R. Moxley, J. McArthur, 2013, Journal of NeuroVirology.

Effect of ageing on neurocognitive function by stage of HIV infection: evidence from the Multicenter AIDS Cohort Study.

J. Becker, O. Selnes, D. Ostrow, 2017, The lancet. HIV.

Randomized trial of central nervous system-targeted antiretrovirals for HIV-associated neurocognitive disorder.

R. Haubrich, F. Vaida, R. Heaton, 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Highlights of the Global HIV-1 CSF Escape Consortium Meeting, 9 June 2016, Bethesda, MD, USA

A. Winston, R. Swanstrom, R. Price, 2016, Journal of virus eradication.

Abstracts from the 12th International Symposium on NeuroVirology

I. Grant, R. Paul, R. Heaton, 2013, Journal of NeuroVirology.

Paroxetine and fluconazole therapy for HIV-associated neurocognitive impairment: results from a double-blind, placebo-controlled trial

R. Moxley, J. McArthur, M. Mielke, 2018, Journal of NeuroVirology.

Minocycline treatment for HIV-associated cognitive impairment

D. Clifford, R. Ellis, M. Zink, 2011, Neurology.

Frequency of and risk factors for HIV dementia in an HIV clinic in sub-Saharan Africa

N. Nakasujja, N. Sacktor, J. McArthur, 2007, Neurology.

Inter-rater reliability of a clinical staging of HIV-associated cognitive impairment

K. Marder, Y. Stern, O. Selnes, 2003, Neurology.

Factors associated with incident human immunodeficiency virus-dementia.

K. Marder, Y. Stern, O. Selnes, 2001, Archives of neurology.

Transdermal selegiline in HIV-associated cognitive impairment: Pilot, placebo-controlled study

K. Marder, M. Mcdermott, K. Kieburtz, 2000, Neurology.

Improvement in HIV-associated motor slowing after antiretroviral therapy including protease inhibitors.

O. Selnes, J. McArthur, N. Sacktor, 2000, Journal of neurovirology.

The BIOCARD Index: A Summary Measure to Predict Onset of Mild Cognitive Impairment

M. Albert, R. Turner, M. Grega, 2017, Alzheimer disease and associated disorders.

Cognitive changes preceding clinical symptom onset of mild cognitive impairment and relationship to ApoE genotype.

M. Albert, G. Mckhann, O. Selnes, 2014, Current Alzheimer research.

Longitudinally preserved psychomotor performance in long-term asymptomatic HIV-infected individuals

J. Margolick, J. Becker, O. Selnes, 2007, Neurology.

HIV-Associated Neurocognitive Disorders

I. Grant, N. Sacktor, 2011 .

NeuroAIDS in Africa

C. Adebamowo, I. Grant, R. Paul, 2010, Journal of NeuroVirology.

Cleavage of cystatin C in the cerebrospinal fluid of patients with multiple sclerosis

Justin C McArthur, Caroline Anderson, Peter A Calabresi, 2006, Annals of neurology.

HIV-associated cognitive impairment in sub-Saharan Africa—the potential effect of clade diversity

D. Clifford, N. Nakasujja, N. Sacktor, 2007, Nature Clinical Practice Neurology.

Platelet decline as a predictor of brain injury in HIV infection

J. Becker, O. Selnes, E. Miller, 2011, Journal of NeuroVirology.

Platelet decline: an avenue for investigation into the pathogenesis of human immunodeficiency virus -associated dementia.

K. Marder, M. Mcdermott, J. Mankowski, 2007, Archives of neurology.

Changing clinical phenotypes of HIV-associated neurocognitive disorders

N. Sacktor, Ned Sacktor, 2018, Journal of NeuroVirology.

Mixed membership trajectory models of cognitive impairment in the multicenter AIDS cohort study

B. Junker, J. Becker, L. Kingsley, 2015, AIDS.

Markers of immune activation and viral load in HIV-associated sensory neuropathy

K. Marder, M. Mcdermott, K. Kieburtz, 2005, Neurology.

Psychiatric issues and human immunodeficiency virus-associated dementia

N. Sacktor, 1998 .

Neurocognitive SuperAging in Older Adults Living With HIV: Demographic, Neuromedical and Everyday Functioning Correlates

Jessica L. Montoya, D. Jeste, I. Grant, 2019, Journal of the International Neuropsychological Society.

Neurocognitive Complications of HIV Infection in Low-Income Countries.

N. Sacktor, K. Robertson, A. Vecchio, 2019, Current topics in behavioral neurosciences.

Distal Sensory Peripheral Neuropathy in Human Immunodeficiency Virus Type 1-Positive Individuals Before and After Antiretroviral Therapy Initiation in Diverse Resource-Limited Settings.

C. Marra, C. Hall, N. Sacktor, 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Polyamines: Predictive Biomarker for HIV-Associated Neurocognitive Disorders

S. Merali, K. Khalili, N. Sacktor, 2014, Journal of AIDS & clinical research.

Polyamines: Predictive Biomarker for HIV-Associated Neurocognitive

S. Merali, K. Khalili, N. Sacktor, 2014 .

HIV and the Brain

K. Tashima, R. Paul, V. Valcour, 2009 .

HIV-associated dementia and aging

V. Valcour, N. Sacktor, 2002 .

Psychomotor slowing in HIV infection: a predictor of dementia, AIDS and death.

D R Hoover, O. Selnes, C. Kleeberger, 1996, Journal of neurovirology.

Cerebrospinal fluid biomarkers and HIV-associated neurocognitive disorders in HIV-infected individuals in Rakai, Uganda

N. Nakasujja, D. Boulware, R. Gray, 2016, Journal of NeuroVirology.

A lipid storage–like disorder contributes to cognitive decline in HIV-infected subjects

P. Calabresi, I. Grant, Linda Chang, 2013, Neurology.

Brain metabolism and cognitive impairment in HIV infection: a 3-T magnetic resonance spectroscopy study.

O. Selnes, M. Pomper, P. Barker, 2010, Magnetic resonance imaging.

Microglial activation is inversely associated with cognition in individuals living with HIV on effective antiretroviral therapy

Jennifer M. Coughlin, M. Pomper, C. Endres, 2018, AIDS.

Regional brain distribution of translocator protein using [11C]DPA-713 PET in individuals infected with HIV

Jennifer M. Coughlin, B. Caffo, T. Guilarte, 2014, Journal of NeuroVirology.

Inflammation and Risk of Depression in HIV: Prospective Findings From the Multicenter AIDS Cohort Study.

M. Irwin, Steven Wolinsky, N. Sacktor, 2019, American journal of epidemiology.

A comparison of cerebral SPECT abnormalities in HIV-positive homosexual men with and without cognitive impairment.

R. V. Van Heertum, K. Marder, J. Gorman, 1995, Archives of neurology.

Response to systemic HIV viral load suppression correlates with psychomotor speed performance

J. Becker, O. Selnes, E. Miller, 2003, Neurology.

CSF antiretroviral drug penetrance and the treatment of HIV-associated psychomotor slowing

J. Becker, O. Selnes, E. Miller, 2001, Neurology.

Visceral fat is associated with brain structure independent of human immunodeficiency virus infection status

J. Becker, W. Post, E. Miller, 2017, Journal of NeuroVirology.

Converging roles for sphingolipids and cell stress in the progression of neuro-AIDS.

J. McArthur, N. Sacktor, A. Nath, 2008, Frontiers in bioscience : a journal and virtual library.

Comparison of scales to evaluate the progression of HIV-associated neurocognitive disorder.

O. Selnes, R. Moxley, J. McArthur, 2010, HIV therapy.

Human immunodeficiency virus neurological complications: an overview of the Ugandan experience.

N. Nakasujja, N. Sacktor, K. Robertson, 2005, Journal of neurovirology.

Prevalence of and risk factors for peripheral neuropathy in Rakai, Uganda

N. Nakasujja, R. Gray, N. Sacktor, 2015 .

Peripheral neuropathy in HIV-infected and uninfected patients in Rakai, Uganda

N. Nakasujja, R. Gray, N. Sacktor, 2017, Neurology.

Characterization of Nitrotyrosine-Modified Proteins in Cerebrospinal Fluid

J. McArthur, N. Sacktor, A. Nath, 2010, Clinical Proteomics.

Insulin Resistance Is Associated With Cognition Among HIV-1-Infected Patients: The Hawaii Aging With HIV Cohort

O. Selnes, R. Paul, V. Valcour, 2006, Journal of acquired immune deficiency syndromes.

Longitudinal neuropsychological test performance among HIV seropositive individuals in Uganda

O. Okonkwo, N. Nakasujja, N. Sacktor, 2013, Journal of NeuroVirology.

No association between Apoε4 alleles, HIV infection, age, neuropsychological outcome, or death

J. Becker, L. Kingsley, S. Penugonda, 2015, Journal of NeuroVirology.

Neurologic disorders incidence in HIV+ vs HIV− men

E. Miller, J. McArthur, N. Sacktor, 2012, Neurology.

Changes in Cognition Precede Changes in HRQoL Among HIV+ Males: Longitudinal Analysis of the Multicenter AIDS Cohort Study

J. Becker, E. Miller, E. Martin, 2019, Neuropsychology.

A novel computerized functional assessment for human immunodeficiency virus-associated neurocognitive disorder

O. Selnes, R. Moxley, J. McArthur, 2013, Journal of NeuroVirology.

Early-career research education mentoring: a successful program in NeuroHIV and mental health (TRNAMH)

Amanda M. Brown, B. Ances, J. Mankowski, 2023, NeuroImmune Pharmacology and Therapeutics.

Impaired insulin sensitivity is associated with worsening cognition in HIV-infected patients

J. Margolick, I. Grant, T. Marcotte, 2019, Neurology.

Clinical trials in HIV-associated cognitive impairment: Cognitive and functional outcomes

K. Marder, Y. Stern, O. Selnes, 2001, Neurology.

Tablet-Based Cognitive Impairment Screening for Adults With HIV Seeking Clinical Care: Observational Study

Richard D Moore, T. Marcotte, M. Merickel, 2021, JMIR mental health.

Tablet-Based Cognitive Impairment Screening for Adults With HIV Seeking Clinical Care: Observational Study

Richard D Moore, T. Marcotte, N. Sacktor, 2020, JMIR mental health.

HIV Associated Neurocognitive Impairment in Diverse Resource Limited Settings.

C. Marra, C. Hall, N. Sacktor, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Undetectable Cerebrospinal Fluid HIV RNA and β-2 Microglobulin Do Not Indicate Inactive AIDS Dementia Complex in Highly Active Antiretroviral Therapy-Treated Patients

J. Catalan, K. Marder, D. Clifford, 2005, Journal of acquired immune deficiency syndromes.

Neuroprotective therapy for HIV dementia.

N. Sacktor, K. Conant, A. Nath, 2003, Current HIV research.

Detection of anti-tat antibodies in CSF of individuals with HIV-associated neurocognitive disorders

J. McArthur, N. Sacktor, A. Nath, 2013, Journal of NeuroVirology.

HIV-1 and TB Co-infection in Multinational Resource Limited Settings: Increased neurological dysfunction.

C. Marra, R. Price, U. Lalloo, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Association of midlife smoking status with change in processing speed and mental flexibility among HIV-seropositive and HIV-seronegative older men: the Multicenter AIDS Cohort Study

J. Becker, R. Beyth, S. Shoptaw, 2016, Journal of NeuroVirology.

Prospects for therapy of HIV-associated neurologic diseases.

N. Sacktor, J. McArthur, 1997, Journal of neurovirology.

Neuropsychological test performance before and after HIV-1 seroconversion: the Multicenter AIDS Cohort Study

J. Becker, O. Selnes, E. Miller, 2013, Journal of NeuroVirology.

Selegiline and oxidative stress in HIV-associated cognitive impairment

C. Yiannoutsos, T. Ernst, D. Clifford, 2009, Neurology.

Selegiline Transdermal System (STS) for HIV-Associated Cognitive Impairment: Open-Label Report of ACTG 5090

D. Clifford, R. Ellis, C. Marra, 2007, HIV clinical trials.

NIH Workshop on HIV-Associated Comorbidities, Coinfections, and Complications: Summary and Recommendation for Future Research.

R. Detels, M. Mugavero, N. Sacktor, 2021, Journal of acquired immune deficiency syndromes.

Long-term predictive value of the Framingham Risk Score for Stroke in HIV-positive vs HIV-negative men

Bryan R. Smith, J. Phair, J. Becker, 2013, Neurology.

Older individuals with HIV infection have greater memory deficits than younger individuals

O. Selnes, J. McArthur, N. Sacktor, 2013, Journal of NeuroVirology.

Factor analysis of proton MR spectroscopic imaging data in HIV infection: metabolite-derived factors help identify infection and dementia.

E. Halpern, O. Selnes, M. Pomper, 2010, Radiology.

Evaluating the accuracy of self-report for the diagnosis of HIV-associated neurocognitive disorder (HAND): defining “symptomatic” versus “asymptomatic” HAND

F. Vaida, C. Fennema-Notestine, I. Grant, 2016, Journal of NeuroVirology.

International neurocognitive normative study: neurocognitive comparison data in diverse resource-limited settings: AIDS Clinical Trials Group A5271

C. Marra, N. Sacktor, K. Robertson, 2016, Journal of Neurovirology.

Utility of the International HIV Dementia Scale for HIV-Associated Neurocognitive Disorder.

N. Nakasujja, R. Gray, N. Sacktor, 2020, Journal of acquired immune deficiency syndromes.

Effect of HIV Subtype and Antiretroviral Therapy on HIV-Associated Neurocognitive Disorder Stage in Rakai, Uganda

N. Nakasujja, R. Gray, N. Sacktor, 2019, Journal of acquired immune deficiency syndromes.

Caregiver versus self-reported activities of daily living among HIV-positive persons in Rakai, Uganda

N. Nakasujja, R. Gray, N. Sacktor, 2018, AIDS care.

Cerebral single-photon emission computed tomography abnormalities in human immunodeficiency virus type 1-infected gay men without cognitive impairment.

R. V. Van Heertum, K. Marder, J. Gorman, 1995, Archives of neurology.

Optimal metrics for identifying long term patterns of depression in older HIV-infected and HIV-uninfected men who have sex with men

Nicole M. Armstrong, M. Irwin, N. Sacktor, 2019, Aging & mental health.

Human Immunodeficiency Virus-Associated Dementia

O. Selnes, J. McArthur, N. Sacktor, 1999, Seminars in neurology.

HIV subtype is not associated with dementia among individuals with moderate and advanced immunosuppression in Kampala, Uganda

O. Laeyendecker, O. Okonkwo, T. Quinn, 2014, Metabolic Brain Disease.

HIV-1 reverse transcriptase sequence in plasma and cerebrospinal fluid of patients with AIDS dementia complex treated with Abacavir

J. Catalan, K. Marder, D. Clifford, 2001, AIDS.

Factors in AIDS Dementia Complex Trial Design: Results and Lessons from the Abacavir Trial

J. Catalan, K. Marder, D. Clifford, 2007, PLoS clinical trials.

The Veterans Aging Cohort Study Index is not associated with HIV-associated neurocognitive disorders in Uganda

N. Nakasujja, R. Gray, N. Sacktor, 2019, Journal of NeuroVirology.

Antiretroviral therapy improves cognitive impairment in HIV+ individuals in sub-Saharan Africa

N. Nakasujja, N. Sacktor, K. Robertson, 2006, Neurology.

Identification of putative biomarkers for HIV-associated neurocognitive impairment in the CSF of HIV-infected patients under cART therapy determined by mass spectrometry

Linda Chang, R. Chaerkady, R. Moxley, 2014, Journal of NeuroVirology.

Interleukin-6 is associated with mortality and neuropsychiatric outcomes in antiretroviral-naïve adults in Rakai, Uganda

N. Nakasujja, R. Gray, N. Sacktor, 2019, Journal of NeuroVirology.

Impact of minocycline on cerebrospinal fluid markers of oxidative stress, neuronal injury, and inflammation in HIV-seropositive individuals with cognitive impairment

Julia L. Drewes, D. Clifford, M. Zink, 2014, Journal of NeuroVirology.

Headache prevalence and its functional impact among HIV-infected adults in rural Rakai District, Uganda

N. Nakasujja, R. Gray, N. Sacktor, 2019, Journal of NeuroVirology.

Cross-sectional analysis of cognitive function using multivariate normative comparisons in men with HIV disease

J. Becker, L. Kingsley, A. Ragin, 2019 .

Baseline neurocognitive impairment (NCI) is associated with incident frailty but baseline frailty does not predict incident NCI in older persons with HIV.

R. Ellis, F. Palella, N. Sacktor, 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

White matter damage, neuroinflammation, and neuronal integrity in HAND

C. Fennema-Notestine, I. Grant, R. Heaton, 2018, Journal of NeuroVirology.

Neuropsychological changes in efavirenz switch regimens.

Yu Cheng, J. Becker, A. Ragin, 2019, AIDS.

Protein-Free Efavirenz Concentrations in Cerebrospinal Fluid and Blood Plasma Are Equivalent: Applying the Law of Mass Action To Predict Protein-Free Drug Concentration

J. McArthur, N. Sacktor, C. Hendrix, 2013, Antimicrobial Agents and Chemotherapy.

Predictors of worsening neuropathy and neuropathic pain after 12 years in people with HIV

R. Heaton, D. Clifford, N. Calcutt, 2020, Annals of clinical and translational neurology.

Human immunodeficiency virus-associated dementia: clinical aspects, biology, and treatment.

N. Sacktor, A. Venkataramana, 2008, Handbook of clinical neurology.

CCL3L1 gene copy number in individuals with and without HIV-associated neurocognitive disorder

Amanda M. Brown, K. Marder, G. Schifitto, 2012 .

CCL3L1 gene copy number in individuals with and without HIV-associated neurocognitive disorder

Amanda M. Brown, K. Marder, G. Schifitto, 2012 .

Cerebral single-photon emission computed tomography abnormalities in human immunodeficiency virus type 1-infected gay men without cognitive impairment.

G. Dooneief, N. Sacktor, G. Todak, 1995, Archives of Neurology.

Heterogeneity in neurocognitive change trajectories among people with HIV starting antiretroviral therapy in Rakai, Uganda

T. Quinn, S. Lofgren, N. Nakasujja, 2019, Journal of NeuroVirology.

Reply to Haddow et al.

F. Vaida, C. Fennema-Notestine, A. Gamst, 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Changing clinical phenotypes of HIV-associated neurocognitive disorders

N. Sacktor, 2017, Journal of NeuroVirology.

HIV immune complexes prevent excitotoxicity by interaction with NMDA receptors

N. Sacktor, A. Nath, M. Bianchet, 2013, Neurobiology of Disease.

Dendritic Spine Injury Induced by the 8-Hydroxy Metabolite of Efavirenz

J. McArthur, N. Sacktor, Namandjé N. Bumpus, 2012, Journal of Pharmacology and Experimental Therapeutics.

Brain structural correlates of trajectories to cognitive impairment in men with and without HIV disease

B. Junker, J. Becker, L. Kingsley, 2019, Brain Imaging and Behavior.

NeuroAIDS in Africa

C. Adebamowo, I. Grant, D. Clifford, 2010, Journal of NeuroVirology.